Opioid Prescribing Patterns Before, During, and After Critical Illness: An Observational Study
Open Access
- 26 July 2022
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Explorations
- Vol. 4 (7), e0735
- https://doi.org/10.1097/cce.0000000000000735
Abstract
OBJECTIVES: The association between opioid therapy during critical illness and persistent opioid use after discharge is understudied relative to ICU opioid exposure and modifiable risk factors. Our objectives were to compare persistent opioid use after discharge among patients with and without chronic opioid use prior to admission (OPTA) and identify risk factors associated with persistent use. DESIGN: Retrospective cohort study. SETTING: Medical, trauma/surgical, or neurologic ICU at an academic hospital. PARTICIPANTS: Adult patients surviving hospital admission. INTERVENTIONS: Opioid use during the ICU and post-ICU stays. MEASUREMENTS AND MAIN RESULTS: The primary outcome was persistent opioid use accounting for greater than 70% of days 4–6 months after discharge. Among 2,975 included patients, 257 (8.6%) were classified as OPTA, and 305 (10.2%) persistently filled opioid prescriptions, including 186/257 (72%) OPTA and 119/2,718 (4.4%) with no chronic opioid fills prior to admission. Among all patients, OPTA was strongly associated with persistent opioid use (odds ratio, 57.2 [95% CI, 41.4–80.0]). Multivariable logistic regression revealed that male sex, surgical procedure, and ICU opioid-free days were associated with reduced persistent opioid use for OPTA patients. Age and ICU opioid-free days were associated with reduced persistent opioid use for non-OPTA patients. Total ICU opioid dose and dose per day of ICU exposure were not associated with persistent use for either group. CONCLUSIONS: In this mixed cohort of ICU patients, 10.2% persistently filled opioid prescriptions 4–6 months after discharge. Although ICU opioid doses were not associated with persistent use, duration of ICU opioid administration is a modifiable risk factor that may reduce persistent opioid use after critical illness.Keywords
This publication has 26 references indexed in Scilit:
- History of The Joint Commission’s Pain StandardsJAMA, 2017
- Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative PeriodJAMA Internal Medicine, 2016
- CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016JAMA, 2016
- Is Admission to the Intensive Care Unit Associated With Chronic Opioid Use? A 4-Year Follow-Up of Intensive Care Unit SurvivorsJournal of Intensive Care Medicine, 2015
- Chronic Use of Opioid Medications Before and After Bariatric SurgeryJAMA, 2013
- Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care UnitCritical Care Medicine, 2013
- Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adultCritical Care Medicine, 2002
- Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unitCritical Care Medicine, 1995
- Pain experiences of intensive care unit patients.1990
- Addiction Rare in Patients Treated with NarcoticsThe New England Journal of Medicine, 1980